Evidence map›Paper›PMID 29408880›Full record

ArticlePloS one2018

Daily visual stimulation in the critical period enhances multiple aspects of vision through BDNF-mediated pathways in the mouse retina.

Amanda M Mui, Victoria Yang, Moe H Aung, Jieming Fu, Adewumi N Adekunle, Brian C Prall, Curran S Sidhu, Han Na Park, Jeffrey H Boatright, P Michael Iuvone and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Model of naturally occurring refractive error (NORE) in mice.bioRxiv : the preprint server for biology · 2026
    Article
  2. Learning as the unifying mechanism of psychedelic action.Journal of psychopharmacology (Oxford, England) · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Acupuncture for pediatric bilateral amblyopia.Integrative medicine research · 2020
    Article
  11. Article
  12. MEF2C and HDAC5 regulateNeuronal signaling · 2020
    Article
  13. Article
  14. Article
  15. Neuroprotective strategies for retinal disease.Progress in retinal and eye research · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Amanda M MuiDepartment of Ophthalmology, Emory University, Atlanta, GA, United States of America.
Victoria YangCenter for Visual and Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA, United States of America.
Moe H AungNeuroscience Program, Emory University, Atlanta, GA, United States of America.
Jieming FuCenter for Visual and Neurocognitive Rehabilitation, Atlanta VA Medical Center, Decatur, GA, United States of America.
Adewumi N AdekunleDepartment of Ophthalmology, Emory University, Atlanta, GA, United States of America.
Brian C PrallDepartment of Ophthalmology, Emory University, Atlanta, GA, United States of America.
Curran S SidhuDepartment of Ophthalmology, Emory University, Atlanta, GA, United States of America.
Han Na ParkDepartment of Ophthalmology, Emory University, Atlanta, GA, United States of America.
Jeffrey H BoatrightDepartment of Ophthalmology, Emory University, Atlanta, GA, United States of America.
P Michael IuvoneDepartment of Ophthalmology, Emory University, Atlanta, GA, United States of America.
Machelle T PardueDepartment of Ophthalmology, Emory University, Atlanta, GA, United States of America.ORCID 0000-0001-8738-6839
Emory University · USGeorgia Institute of Technology · US

Funding

P30-Core Grant for Vision Research Core CP30EY006360 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 1986 to 2025
$15.3M
Neuromodulators and Circadian Clocks: Roles in Retinal Function and DysfunctionR01EY004864 · NEI · EMORY UNIVERSITY · PI IUVONE, P MICHAEL · 1985 to 2018
$7.0M
Retinal Mechanisms of Refractive DevelopmentR01EY016435 · NEI · GEORGIA INSTITUTE OF TECHNOLOGY · PI Machelle T. Pardue · 2009 to 2026
$5.4M
Oligonucleotide Repair of a Retinal Degeneration ModelR01EY014026 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H · 2004 to 2015
$4.1M
Ocular Growth, Emmetropia, and Interphotoreceptor Retinoid-Binding Protein (IRBP)R01EY021592 · NEI · EMORY UNIVERSITY · PI BOATRIGHT, JEFFREY H, IUVONE, P MICHAEL · 2013 to 2021
$3.3M
NEI NIH HHS P30 EY006360NEI NIH HHS R01 EY004864NEI NIH HHS R01 EY014026NEI NIH HHS R01 EY016435NEI NIH HHS R01 EY021592
6 · The paper itself

Abstract

Visual experience during the critical period modulates visual development such that deprivation causes visual impairments while stimulation induces enhancements. This study aimed to determine whether visual stimulation in the form of daily optomotor response (OMR) testing during the mouse critical period (1) improves aspects of visual function, (2) involves retinal mechanisms and (3) is mediated by brain derived neurotrophic factor (BDNF) and dopamine (DA) signaling pathways. We tested spatial frequency thresholds in C57BL/6J mice daily from postnatal days 16 to 23 (P16 to P23) using OMR testing. Daily OMR-treated mice were compared to littermate controls that were placed in the OMR chamber without moving gratings. Contrast sensitivity thresholds, electroretinograms (ERGs), visual evoked potentials, and pattern ERGs were acquired at P21. To determine the role of BDNF signaling, a TrkB receptor antagonist (ANA-12) was systemically injected 2 hours prior to OMR testing in another cohort of mice. BDNF immunohistochemistry was performed on retina and brain sections. Retinal DA levels were measured using high-performance liquid chromatography. Daily OMR testing enhanced spatial frequency thresholds and contrast sensitivity compared to controls. OMR-treated mice also had improved rod-driven ERG oscillatory potential response times, greater BDNF immunoreactivity in the retinal ganglion cell layer, and increased retinal DA content compared to controls. VEPs and pattern ERGs were unchanged. Systemic delivery of ANA-12 attenuated OMR-induced visual enhancements. Daily OMR testing during the critical period leads to general visual function improvements accompanied by increased DA and BDNF in the retina, with this process being requisitely mediated by TrkB activation. These results suggest that novel combination therapies involving visual stimulation and using both behavioral and molecular approaches may benefit degenerative retinal diseases or amblyopia.

Indexed as

Photic StimulationVisual AcuityAnimalsBrain-Derived Neurotrophic FactorChromatography, High Pressure LiquidContrast SensitivityDopamineElectroretinographyEvoked Potentials, VisualMiceMice, Inbred C57BLRetinaSignal TransductionBrain-Derived Neurotrophic FactorDopamine

Identifiers

PMID29408880
PMCPMC5800661
OpenAlexW2794239655

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.